We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

October 11, 2019

Digital Health in Asia - Well, Shanghai and Tokyo.

Events
Martin Kelly
&
Chandana Fitzgerald

A good part of September was spent in Asia at our gatherings in Shanghai and Tokyo at JLabs and IBM respectively. Over the last 5 years, we have been hosting these events all around the globe but this was a first for HealthXL and we thoroughly enjoyed it while also learning lots of new things. 

A good part of September was spent in Asia at our gatherings in Shanghai and Tokyo at JLabs and IBM respectively. Over the last 5 years, we have been hosting these events all around the globe but this was our first time in these dynamic cities.  

We’re pretty optimistic you have heard about the large investment and commercial deals happening in China. You have also probably read about the scale of the opportunity. You may have also heard of the dearth of doctors and issues with access to healthcare for large rural populations. 

It is hard not to be both excited and overwhelmed by the sheer magnanimity of it all. 

A couple of things on the day really hit home. Feng Ge (CEO - Jiahui International Hospital) explained how his trojan horse strategy to digital transformation starts with building a new hospital and partnering with one of the leading US health systems (Partners/Harvard). While a Kaiser like ‘all-in-one’ model does not exist in China, his team have decided to create one! The logic is you need the best doctors to attract consumers.  In addition, you need a new facility/site if you want to create the ideal holistic model leveraging digital. So, you have to build a new epicenter, and branch out to all aspects of health and care-giving from the centre. 

Given the shortage of healthcare professionals in China, it seems obvious that AI has to play a new role in supporting the needs of a burgeoning market. Marco Huesch (CMO and Managing Director - Ping An) explained how they are approaching the opportunity that Asia presents. He gave us the lay of the land on the foundation and structure of Chinese healthcare, and of gaps and opportunities.


What we found most inspiring is the lack of legacy. Nobody was debating the definitions of digital health or digital therapeutics or deep learning but rather talking about how to transform the current model, improve access and make money. Quite a refreshing change and a well deserved dose of honesty for those of us gathered!

What ensued were two captivating panel discussions - one with local health tech entrepreneurs, and the second with healthcare leaders from China and abroad. The entrepreneurs focused their discussion on the current landscape of digital health offerings in China - from technology to regulation and adoption, by outlining their own milestones. There was consensus that with government and privately-driven interest & investment in technology, it is an exciting time to be an entrepreneur in China. 

The second discussion was aimed at comparing and contrasting the West with the East so we can be educated on the opportunities and challenges. While everybody (the group comprised of Amy Gu (Hemi Ventures) , Robert Garber (7Wire Ventures), Farhana Nakhooda (Health Catalyst) , Philip Huang, (Roche Diagnostics) and Tony Estrella (Frontiers Health) were excited at the prospect of shared learnings and shared goals however the crux of the matter is that the societies function so differently that one cannot bring any assumptions while investing or partnering in China.  They highlighted the need to invest some serious money since the valuations in China can give Silicon Valley a run for its money.


Shanghai Event Report

Tokyo was both similar and different. Both are mega cities but in very different ways. Shanghai bursts with energy, bedazzled buildings and light shows on steroids (thanks to Golden Week) while Tokyo is strangely orderly given a population of over 30 million.


Our meeting in Tokyo focused on two topics where Japan is seen as a leader. AI and Senior Care, balancing a respect for tradition with a passion for the future. We captured opinions from Motoo Kusakabe (Open City Institute), Norishige Morimot (IBM) , Terry Sweeney (Watson Health), Jim Joyce (Health Beacon). 

Overall, a couple of themes stood out. First, user-centric design is paramount, and great technology including AI should be invisible. Much like how Tokyo, as a city, is designed - everything is organized, clean, pristine. Complexity was hidden and the design champions function and elegance. These qualities seem innate to every individual, and permeates society.  Second, a recognition of the holistic nature of health and wellbeing, as highlighted in Motoo’s presentation. 





A third, unspoken theme at Tokyo, was the excitement of the Rugby World Cup. Ireland’s loss to Japan in one match that coincided with our meeting (incidentally, of course) did not sully any spirits thanks to the healthcare leaders who came together to learn and share. There were only winners at this one!

Tokyo Event Report


If you are interested in learning about these markets (APAC), reach out to us and we can talk! 



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Prescription DTx - Commercialization Models & Adoption

21st September @ 10:45AM EDT

Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Medtech partnerships

23rd September @ 10:45AM EDT

Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx in Mental Health: Scaling access to care - Fireside chat with Big Health Co-founder & CEO Peter Hames

23rd September @ 10:00AM EDT

Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.

Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: DTx for Mental Health

28th September @ 10:45AM EDT

This series of 2 meetings to discuss in detail with other senior leaders the current state of DTx in mental health, what indications are best suited to such interventions, and commercial opportunities that they present.  Perfect opportunity to listen, engage and enjoy.

Featuring
Krys Zaluski
Krys Zaluski
Director Of Business Development - Digital Health at Sunovion Pharmaceuticals
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall
Featuring
Krys Zaluski
Krys Zaluski
Director Of Business Development - Digital Health at Sunovion Pharmaceuticals
Francesca Wuttke
Francesca Wuttke
Chief Digital Officer, Almirall

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Sprint: Prescription DTx - Commercialization Models & Adoption

21st September @ 10:45AM EDT

Join this series of 2 meetings to discuss with other senior leaders Commercialization Models & Adoption in Prescription DTx. Limited spaces available so apply now to secure your place in the conversation.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wire Ventures
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Commercialization models for Virtual Care in Cardiometabolic Diseases

21st September @ 9:45AM EDT

Join us as we discuss commercialization models for Virtual Care in Cardiometabolic Diseases. Our 75 minute sessions are highly interactive and give attendees the opportunity to hear from senior leaders in the space and also share their own thoughts on the topic

Featuring
Shahram Sharif
Shahram Sharif
Board Director, LindaCare
Abhishek Shah
Abhishek Shah
CEO, Wellthy Therapeutics
Featuring
Shahram Sharif
Shahram Sharif
Board Director, LindaCare
Abhishek Shah
Abhishek Shah
CEO, Wellthy Therapeutics
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Medtech partnerships

23rd September @ 10:45AM EDT

Join us in this informal conversation with senior leaders how DTx companies should think about Medtech as the appropriate partner and vice versa. Apply now to connect with peers and network with new people.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Sean Cheng
Sean Cheng
VC Investor, Philips Ventures
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx in Mental Health: Scaling access to care - Fireside chat with Big Health Co-founder & CEO Peter Hames

23rd September @ 10:00AM EDT

Do you want to learn from one of the top DTx companies in mental health? Join us in this exclusive fireside chat with Peter Hames, co-Founder and CEO at Big Health, where we will talk about the early days of DTx in mental health, Big Health’s differentiated commercialization models, industry leading clinical evidence and the significant opportunity to address the mental health crisis by expanding access to mental health care.

Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL
Featuring
Peter Hames
Peter Hames
Co-Founder & CEO of Big Health
Martin Kelly
Martin Kelly
Co-founder & CEO, HealthXL

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.